First-line anti-TB drug resistance pattern and its trend in the national TB referral center in Iran Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008
First line anti-tuberculous drug resistance prevalence and its pattern among HIV infected patients in the national referral TB center, Iran Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009
Study of drug resistance profile in Multidrug resistant tuberculosis (MDR TB) patients attending a tertiary care hospital at Mumbai. Source: International Congress 2017 – TB: diagnosis, severity and practical management Year: 2017
Spreading of resistance to group A anti-tuberculosis drugs among TB patients in Astana city Source: International Congress 2018 – Drug-resistant tuberculosis and the sequelae of pulmonary tuberculosis Year: 2018
Prevalance of initial and acquired resistance to antituberculosis drugs in our clinic Source: Eur Respir J 2005; 26: Suppl. 49, 653s Year: 2005
Incidence of cycloserine induced neurotoxicity in drug resistant TB patients attending a tertiary care hospital. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Pattern of antibiotic resistance in hospital acquired pneumonia in a country where antibiotics are available over the counter without doctors prescription Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
Antituberculous drug resistance rates in soldier patients newly diagnosed with TB in Turkey Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Second-line tuberculosis drug resistance study from a referal center of Turkey Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II Year: 2008
Treatment outcome of multi-drug resistant tuberculosis (MDR-TB) patients at a tertiary care center of Northern India. Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II Year: 2019
Evaluation the drug susceptibility testing and the prevalence of resistance to antituberculosis drugs in a chronic department Source: Eur Respir J 2003; 22: Suppl. 45, 520s Year: 2003
Pharmacoepidemiology of antibiotics using for treatment severe pulmonary infections in a clinical city hospital Source: Eur Respir J 2005; 26: Suppl. 49, 640s Year: 2005
Antituberculosis drug resistance in a secondary care hospital in Turkey Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control Year: 2007
Resistance to second-line antituberculous drugs of Mtb strains in TB institute clinic Source: Eur Respir J 2007; 30: Suppl. 51, 442s Year: 2007
The association between HIV and antituberculosis drug resistance Source: Eur Respir J 2008; 32: 718-725 Year: 2008
Frequency of risk factors for multi-drug resistant tuberculosis among the patients enrolled at multi-drug resistant clinic in a tertiary care hospital, Pakistan Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Frequency of drug resistance and treatment results in patients with newly detected tuberculosis using standard chemotherapeutical regimen on the data of district hospital, Kiev Source: Eur Respir J 2002; 20: Suppl. 38, 402s Year: 2002
Frequency of drug resistance and treatment results with standard chemotherapeutical regimen in patients with newly detected tuberculosis on the data of district hospital, Kiev Source: Eur Respir J 2002; 20: Suppl. 38, 548s Year: 2002
Bacteriological conversion in XDR-TB and RR-TB patients with fluoroquinolone resistance treated with and without new and repurposed anti-TB drugs in Azerbaijan prisons Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018
Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre Source: Eur Respir J 2003; 22: Suppl. 45, 524s Year: 2003